{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:22:07Z","timestamp":1791346927197,"version":"4.3.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1038\/4716","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:58Z","timestamp":1027672498000},"page":"34-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":267,"title":["In vivo migration and function of transferred HIV-1-specific cytotoxic T cells"],"prefix":"10.1038","volume":"5","author":[{"given":"Scott J.","family":"Brodie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Lewinsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce K.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jiyamapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley R.","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm0199_34_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-71272-2_1","volume":"128","author":"GL Ada","year":"1986","unstructured":"Ada, G.L. & Jones, P.D. The immune response to influenza virus. Cur. Top. Microbiol. Immunol. 128, 1\u201354 (1986).","journal-title":"Cur. Top. Microbiol. Immunol."},{"key":"BFnm0199_34_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.168.3.1163","volume":"168","author":"MJ Cannon","year":"1988","unstructured":"Cannon, M.J., Openshaw, P.J. & Askonas, B.A. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med.  168, 1163\u20131168 ( 1988).","journal-title":"J. Exp. Med."},{"key":"BFnm0199_34_CR3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4049\/jimmunol.136.2.698","volume":"136","author":"JA Byrne","year":"1986","unstructured":"Byrne, J.A. & Oldstone, M.B. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.  J. Immunol. 136, 698\u2013704 (1986).","journal-title":"J. Immunol."},{"key":"BFnm0199_34_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev.iy.13.040195.002553","volume":"13","author":"SR Riddell","year":"1995","unstructured":"Riddell, S.R. & Greenberg, P.D. Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol.  13, 545\u2013586 (1995).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm0199_34_CR5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter, E.A.  et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038\u2013 1044 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0199_34_CR6","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","volume":"83","author":"CR Li","year":"1994","unstructured":"Li, C.R., Greenberg, P.D., Gilbert, M.J., Goodrich, J.M. & Riddell, S.R. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood  83, 1971\u20131979 (1994).","journal-title":"Blood"},{"key":"BFnm0199_34_CR7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V78.5.1373.1373","volume":"78","author":"P Reusser","year":"1991","unstructured":"Reusser, P., Riddell, S.R., Meyers, J.D. & Greenberg, P.D. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78, 1373\u2013 1380 (1991).","journal-title":"Blood"},{"key":"BFnm0199_34_CR8","doi-asserted-by":"publisher","first-page":"10289","DOI":"10.1073\/pnas.94.19.10289","volume":"94","author":"CM Posavad","year":"1997","unstructured":"Posavad, C.M., Koelle, D.M., Shaughnessy, M.F. & Corey, L. Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses.  Proc. Natl. Acad. Sci. USA 94, 10289\u2013 10294 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0199_34_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJM199409083311017","volume":"331","author":"HE Heslop","year":"1994","unstructured":"Heslop, H.E., Brenner, M.K. & Rooney, C.M. Donor T cells to treat EBV-associated lymphoma.  N. Engl. J. Med. 331, 679\u2013680 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0199_34_CR10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","volume":"330","author":"EB Papadopoulos","year":"1994","unstructured":"Papadopoulos, E.B.  et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330, 1185\u2013 1191 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0199_34_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/0952-7915(95)80088-3","volume":"7","author":"JT Safrit","year":"1995","unstructured":"Safrit, J.T. & Koup, R.A. The immunology of primary HIV infection: which immune responses control HIV replication? Curr. Opin. Immunol.  7, 456\u2013461 ( 1995).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnm0199_34_CR12","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/jvi.68.7.4650-4655.1994","volume":"68","author":"RA Koup","year":"1994","unstructured":"Koup, R.A.  et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650\u2013 4655 (1994).","journal-title":"J. Virol."},{"key":"BFnm0199_34_CR13","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/jvi.68.9.6103-6110.1994","volume":"68","author":"P Borrow","year":"1994","unstructured":"Borrow, P., Lewicki, H., Hahn, B.H., Shaw, G.M. & Oldstone, M.B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103\u2013 6110 (1994).","journal-title":"J. Virol."},{"key":"BFnm0199_34_CR14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1056\/NEJM199710303371803","volume":"337","author":"L Musey","year":"1997","unstructured":"Musey, L. et al. Cytotoxic T cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337, 1267\u20131274 ( 1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0199_34_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1056\/NEJM199501263320401","volume":"332","author":"Y Cao","year":"1995","unstructured":"Cao, Y., Qin, L., Zhang, L., Safrit, J. & Ho, D.D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332, 201\u2013208 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0199_34_CR16","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.4049\/jimmunol.156.7.2616","volume":"156","author":"T Harrer","year":"1996","unstructured":"Harrer, T.  et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to  in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156, 2616\u2013 2623 (1996).","journal-title":"J. Immunol."},{"key":"BFnm0199_34_CR17","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1084\/jem.181.4.1365","volume":"181","author":"MR Klein","year":"1995","unstructured":"Klein, M.R.  et al. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med.  181, 1365\u20131372 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnm0199_34_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.177.2.249","volume":"177","author":"A Carmichael","year":"1993","unstructured":"Carmichael, A., Jin, X., Sissons, P. & Borysiewicz, L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1) specific cytotoxic T lymphocytes (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.  J.f Exp. Med. 177, 249\u2013256 (1993).","journal-title":"J.f Exp. Med."},{"key":"BFnm0199_34_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nm0297-212","volume":"3","author":"PJ Goulder","year":"1997","unstructured":"Goulder, P.J.  et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med.  3, 212\u2013217 (1997).","journal-title":"Nature Med."},{"key":"BFnm0199_34_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nm0297-205","volume":"3","author":"P Borrow","year":"1997","unstructured":"Borrow, P.  et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3, 205\u2013 211 (1997).","journal-title":"Nature Med."},{"key":"BFnm0199_34_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/354453a0","volume":"354","author":"RE Phillips","year":"1991","unstructured":"Phillips, R.E.  et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453\u2013459 (1991).","journal-title":"Nature"},{"key":"BFnm0199_34_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0092-8674(94)90417-0","volume":"78","author":"R Cheynier","year":"1994","unstructured":"Cheynier, R.  et al. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphoctyes. Cell  78, 373\u2013387 (1994).","journal-title":"Cell"},{"key":"BFnm0199_34_CR23","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","volume":"279","author":"GS Ogg","year":"1998","unstructured":"Ogg, G.S. et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103\u2013 2105 (1998).","journal-title":"Science"},{"key":"BFnm0199_34_CR24","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1002\/eji.1830271213","volume":"27","author":"G Pantaleo","year":"1997","unstructured":"Pantaleo, G.  et al. Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection. Eur. J. Immunol. 27, 3166\u2013 3173 (1997).","journal-title":"Eur. J. Immunol."},{"key":"BFnm0199_34_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/34929","volume":"391","author":"KL Collins","year":"1998","unstructured":"Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphoctyes. Nature 391, 397\u2013401 (1998).","journal-title":"Nature"},{"key":"BFnm0199_34_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0167-5699(94)90005-1","volume":"15","author":"RM Zinkernagel","year":"1994","unstructured":"Zinkernagel, R.M. & Hengartner, H. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol. Today 15, 262\u2013 268 (1994).","journal-title":"Immunol. Today"},{"key":"BFnm0199_34_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/328348a0","volume":"328","author":"F Plata","year":"1987","unstructured":"Plata, F. et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328, 348\u2013351 (1987).","journal-title":"Nature"},{"key":"BFnm0199_34_CR28","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.4049\/jimmunol.149.9.3113","volume":"149","author":"C Jassoy","year":"1992","unstructured":"Jassoy, C., Johnson, R.P., Navia, B.A., Worth, J. & Walker, B.D. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in the cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149, 3113\u20133119 (1992).","journal-title":"J. Immunol."},{"key":"BFnm0199_34_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm0596-551","volume":"2","author":"HE Heslop","year":"1996","unstructured":"Heslop, H.E.  et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med. 2, 551\u2013555 (1996).","journal-title":"Nature Med."},{"key":"BFnm0199_34_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1126\/science.1352912","volume":"257","author":"SR Riddell","year":"1992","unstructured":"Riddell, S.R.  et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257 , 238\u2013241 (1992).","journal-title":"Science"},{"key":"BFnm0199_34_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/0952-7915(93)90027-P","volume":"5","author":"SR Riddell","year":"1993","unstructured":"Riddell, S.R., Gilbert, M.J. & Greenberg, P.D. CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection. Curr. Opin. Immunol. 5, 484 \u2013491 (1993).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnm0199_34_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nm0296-216","volume":"2","author":"SR Riddell","year":"1996","unstructured":"Riddell, S.R.  et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med.  2, 216\u2013223 (1996).","journal-title":"Nature Med."},{"key":"BFnm0199_34_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/362359a0","volume":"362","author":"J Embretson","year":"1993","unstructured":"Embretson, J.  et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature  362, 359\u2013362 (1993).","journal-title":"Nature"},{"key":"BFnm0199_34_CR34","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nm0798-852","volume":"4","author":"RE Walker","year":"1998","unstructured":"Walker, R.E.  et al. Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults. Nature Med. 4, 852\u2013856 (1998).","journal-title":"Nature Med."},{"key":"BFnm0199_34_CR35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1084\/jem.165.3.650","volume":"165","author":"MJ Reddehase","year":"1987","unstructured":"Reddehase, M.J., Mutter, W. & Koszinowski, U.H. In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection.  J. Exp. Med. 165, 650\u2013656 (1987).","journal-title":"J. Exp. Med."},{"key":"BFnm0199_34_CR36","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/jvi.68.12.8056-8063.1994","volume":"68","author":"M Matloubian","year":"1994","unstructured":"Matloubian, M., Concepcion, R.J. & Ahmed, R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol.  68, 8056\u20138063 (1994).","journal-title":"J. Virol."},{"key":"BFnm0199_34_CR37","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","volume":"278","author":"ES Rosenberg","year":"1997","unstructured":"Rosenberg, E.S.,  et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447\u2013 1450 (1997).","journal-title":"Science"},{"key":"BFnm0199_34_CR38","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1073\/pnas.93.7.2889","volume":"93","author":"C Woffendin","year":"1996","unstructured":"Woffendin, C., Ranga, U., Yang, Z., Xu, L. & Nabel, G.J. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl. Acad. Sci. USA  93, 2889\u20132894 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0199_34_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/369333a0","volume":"369","author":"BH Nelson","year":"1994","unstructured":"Nelson, B.H., Lord, J.D. & Greenberg, P.D. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation.  Nature 369, 333\u2013336 ( 1994).","journal-title":"Nature"},{"key":"BFnm0199_34_CR40","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1126\/science.8493534","volume":"260","author":"BK Patterson","year":"1993","unstructured":"Patterson, B.K.  et al. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry.  Science 260, 976\u2013979 ( 1993).","journal-title":"Science"},{"key":"BFnm0199_34_CR41","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1128\/jvi.69.7.4316-4322.1995","volume":"69","author":"BK Patterson","year":"1995","unstructured":"Patterson, B.K., Goolsby, C., Hodara, V., Lohman, K.L. & Wolinsky, S.M. Detection of CD4+ T cells harboring human immunodeficiency virus type 1 DNA by flow cytometry using simultaneous immunophenotyping and PCR-driven in situ hybridization: evidence of epitope masking of the CD4 cells surface molecule in vivo.  J. Virol. 69, 4316\u20134322 (1995).","journal-title":"J. Virol."},{"key":"BFnm0199_34_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/(SICI)1097-0320(19980401)31:4<265::AID-CYTO6>3.0.CO;2-I","volume":"31","author":"BK Patterson","year":"1998","unstructured":"Patterson, B.K., Mosiman, V.L., Cantarero, L., Bhattacharya, M. & Goolsby, C. Detection of HIV-RNA-positive monocytes in peripheral blood of HIV-positive patients by simultaneous flow cytometric analysis of intracellular HIV RNA and cellular immunophenotype.  Cytometry 31, 265\u2013274 ( 1998).","journal-title":"Cytometry"},{"key":"BFnm0199_34_CR43","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1084\/jem.187.7.1139","volume":"187","author":"LP Yang","year":"1998","unstructured":"Yang, L.P.  et al. Productive infection of neonatal CD8+ T lymphocytes by HIV-1. J. Exp. Med. 187, 1139\u2013 1144 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm0199_34_CR44","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1128\/JVI.72.7.5599-5609.1998","volume":"72","author":"SJ Brodie","year":"1998","unstructured":"Brodie, S.J.  et al. The effects of pharmacological and lentivirus-induced immune suppression on orbivirus pathogenesis: assessment of virus burden in blood monocytes and tissues by reverse transcription-in situ PCR.  J. Virol. 72, 5599\u20135609 (1998).","journal-title":"J. Virol."},{"key":"BFnm0199_34_CR45","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.4049\/jimmunol.153.12.5790","volume":"153","author":"SJ Brodie","year":"1994","unstructured":"Brodie, S.J.  et al. Macrophage function in simian AIDS. Killing defects in vivo are independent of macrophage infection, associated with alterations in Th phenotype, and reversible with IFN-gamma. J. Immunol.  153, 5790\u20135801 (1994).","journal-title":"J. Immunol."},{"key":"BFnm0199_34_CR46","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1128\/JVI.72.5.3863-3871.1998","volume":"72","author":"SJ Brodie","year":"1998","unstructured":"Brodie, S.J.  et al. Epizootic hemorrhagic disease: analysis of tissues by amplification and in situ hybridization reveals widespread orbivirus infection at low copy numbers. J. Virol. 72, 3863\u2013 3871 (1998).","journal-title":"J. Virol."},{"key":"BFnm0199_34_CR47","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1128\/JVI.72.7.6223-6227.1998","volume":"72","author":"C Diamond","year":"1998","unstructured":"Diamond, C.  et al. Human herpesvirus 8 in the prostate glands of men with Kaposi's sarcoma. J. Virol. 72, 6223\u2013 6227 (1998).","journal-title":"J. Virol."},{"key":"BFnm0199_34_CR48","first-page":"250","volume":"146","author":"SJ Brodie","year":"1995","unstructured":"Brodie, S.J.  et al. Ovine lentivirus expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues.  Am. J. Pathol. 146, 250\u2013263 (1995).","journal-title":"Am. J. Pathol."},{"key":"BFnm0199_34_CR49","unstructured":"Fox, C.H. & Cottler-Fox, M. In situ hybridization for detection of HIV RNA. Curr. Protocol. Immunol. 12.18.11\u201321 (1994)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm0199_34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm0199_34","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm0199_34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:11:22Z","timestamp":1743786682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0199_34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["BFnm0199_34"],"URL":"https:\/\/doi.org\/10.1038\/4716","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]},"assertion":[{"value":"29 July 1998","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 1998","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}